EUVIMEDEUVIMED entdecken
Crossref

Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype

Bilge Dundar, Mouaz Alsawas, Amr Masaadeh, Kyle Conway, Anthony N Snow, Ramakrishna R Sompallae, Aaron D Bossler, Deqin Ma, Osorio Lopes Abath Neto

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Bilge Dundar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Isocitrate Dehydrogenase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma, IDH-wild type, the most common malignant primary central nervous system tumor, represents a formidable challenge in clinical management due to its poor prognosis and limited therapeutic responses. With an evolving understanding of its underlying biology, there is an urgent need to identify prognostic molecular groups that can be subject to targeted therapy. This study established a cohort of 124 sequential glioblastomas from a tertiary hospital and aimed to find correlations between molecular features and survival outcomes. Comprehensive molecular characterization of the cohort revealed prevalent alterations as previously described, such as TERT promoter mutations and involvement of the PI3K-Akt-mTOR, CK4/6-CDKN2A/B-RB1, and p14ARF-MDM2-MDM4-p53 pathways. MGMT promoter methylation is a significant predictor of improved overall survival, aligned with previous data. Conversely, age showed a marginal association with higher mortality. Multivariate analysis to account for the effect of MGMT promoter methylation and age showed that, in contrast to other published series, this cohort demonstrated improved survival for tumors harboring PTEN mutations, and that there was no observed difference for most other molecular alterations, including EGFR amplification, RB1 loss, or the coexistence of EGFR amplification and deletion/exon skipping (EGFRvIII). Despite limitations in sample size, this study contributes data to the molecular landscape of glioblastomas, prompting further investigations to examine these findings more closely in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsIsocitrate DehydrogenaseHumansMiddle AgedMaleFemaleAgedAdultMutationCohort StudiesPrognosisBiomarkers, TumorDNA MethylationYoung AdultAged, 80 and overPromoter Regions, GeneticSurvival Analysis

Stichwörter der Autor:innen

EGFR amplificationGlioblastoma IDH-wild typeMGMT promoter methylationMalignant primary brain tumorMolecular characterizationSurvival outcomes

Substanzen

Isocitrate DehydrogenaseBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Mayo Clinic, Rochester, MN, USA.
  • Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. Electronic address: osorio-lopesabathneto@uiowa.edu.

Zitieren

APA

Dundar, B., Alsawas, M., Masaadeh, A., Conway, K., Snow, A. N., Sompallae, R. R., Bossler, A. D., Ma, D., & Lopes Abath Neto, O. (2024). Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155272

Vancouver

Dundar B, Alsawas M, Masaadeh A, Conway K, Snow AN, Sompallae RR, et al. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155272

BibTeX
@article{Dundar2024,
  author = {Dundar, Bilge and Alsawas, Mouaz and Masaadeh, Amr and Conway, Kyle and Snow, Anthony N and Sompallae, Ramakrishna R and Bossler, Aaron D and Ma, Deqin and Lopes Abath Neto, Osorio},
  title = {Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155272}
}
Kostenlos starten →